Vor Biopharma Inc.
Status: Publicly traded
Direct answer
Vor Biopharma Inc. is publicly traded on NASDAQ under the ticker VOR.
Vor Biopharma, Inc. is a clinical-stage biotechnology firm dedicated to developing innovative engineered hematopoietic stem cell (eHSC) therapies for individuals battling cancer. Its lead product candidate, VOR33, is an eHSC therapy currently undergoing Phase 1/2 clinical trials. VOR33 is designed to target acute myeloid leukemia (AML) and various other hematological malignancies. A key feature of VOR33's eHSCs is...
Can you invest in Vor Biopharma Inc.?
Yes. Vor Biopharma Inc. is publicly traded on NASDAQ under the ticker VOR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Vor Biopharma Inc.
Detailed equity research is provided by MarketSnap.